ArticleNPJ breast cancer2019

MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer.

Stephen Johnston et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.